---
figid: PMC6048671__10.1177_1758835918786228-fig1
figtitle: CTLA-4 and PD-1 pathway inhibition
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC6048671
filename: 10.1177_1758835918786228-fig1.jpg
figlink: /pmc/articles/PMC6048671/figure/fig1-1758835918786228/
number: F1
caption: CTLA-4 and PD-1 pathway inhibition. CTLA-4 inhibition allows for activation
  and proliferation of more T-cell clones, and reduces Treg-mediated immunosuppression.
  PD-1 pathway inhibition restores the activity of antitumour T cells that have become
  quiescent.CTLA-4, cytotoxic T-lymphocyte-associated antigen 4; MHC, major histocompatibility
  complex; PD-1, programmed death 1; PD-L, programmed death ligand 1; TCR, T-cell
  receptor; Treg, regulatory T cell.
papertitle: The evolving immunotherapeutic landscape in advanced oesophagogastric
  cancer.
reftext: Michael Flynn, et al. Ther Adv Med Oncol. 2018;10:1758835918786228.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8303979
figid_alias: PMC6048671__F1
figtype: Figure
redirect_from: /figures/PMC6048671__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6048671__10.1177_1758835918786228-fig1.html
  '@type': Dataset
  description: CTLA-4 and PD-1 pathway inhibition. CTLA-4 inhibition allows for activation
    and proliferation of more T-cell clones, and reduces Treg-mediated immunosuppression.
    PD-1 pathway inhibition restores the activity of antitumour T cells that have
    become quiescent.CTLA-4, cytotoxic T-lymphocyte-associated antigen 4; MHC, major
    histocompatibility complex; PD-1, programmed death 1; PD-L, programmed death ligand
    1; TCR, T-cell receptor; Treg, regulatory T cell.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD274
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - HLA-C
  - CTLA4
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Tcr
  - Mhc
  - zip
  - TCR
  - tumour
---
